-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilacidin in Proctitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brilacidin in Proctitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brilacidin in Proctitis Drug Details: Brilacidin (PMX-30063) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilacidin in Chemotherapy Induced Oral Mucositis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brilacidin in Chemotherapy Induced Oral Mucositis Drug Details: Brilacidin (PMX-30063) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilacidin in Inflammatory Bowel Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brilacidin in Inflammatory Bowel Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brilacidin in Inflammatory Bowel Disease Drug Details: Brilacidin (PMX-30063) is under...
-
Track & Monitor
Environmental sustainability in Construction: Radiant heating
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the construction industry’s Radiant heating segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Track & Monitor
Internet of Things in Construction: Radiant heating
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the construction industry’s Radiant heating segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – brilacidin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry brilacidin Drug Details Brilacidin (PMX-30063) is under development for the treatment of acute bacterial...
-
Sector Analysis
Global Spirits Market: News and Events March 2016
The report provides a review of the latest news and key events in the global spirits market during March.
-
Sector Analysis
Global Wine Market: Merger and Acquisitions March 2016
The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global wine market during March.